Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-02

Clinical Trial Update: A Study of T3 Therapy in Patients With Hypothyroidism [Phase 2]

View source ↗

Summary

Phase 2 study of T3 therapy for hypothyroidism has completed, according to the trial update. The document provides the trial status but does not present specifi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • T3 Therapy (triiodothyronine)

Snippet

Sponsor: Ipe, LLC | Conditions: Hypothyroidism | Phase 2 | Status: COMPLETED